Categories: NewsVaccine

Here for Good: Merck’s Steadfast Commitment to Health Equity

How one employee’s upbringing and career journey have motivated her to fight inequities around the world

NORTHAMPTON, MA / ACCESSWIRE / July 16, 2024 / For Priya Agrawal, health equity has been a lifelong concern and a guiding principle in the work she’s done across industries.

As a young girl growing up in central London, Agrawal saw firsthand how inequities even within her own extended family could drastically impact health outcomes.

“I watched my father’s side of the family – who lived in London – live with diabetes, but I watched my mother’s side of the family – who lived in North India – die of diabetes,” Agrawal said. “It took me a while to figure out that it was my father’s family’s access to the National Health Service that made the difference.”

That early insight propelled Agrawal into a career as an obstetrician and gynecologist before moving into public health. She first joined Merck to help launch Merck for Mothers, a global initiative to help create a world where no woman has to die while giving life. From there, she went on to a variety of roles – from lead of the company’s vaccines and contraceptives business in the U.K. to managing director of South Africa and Sub-Saharan Africa to global head of HPV vaccines. She currently serves as vice president of health equity and partnerships.

Agrawal’s work – and the passion that fuels it – continues, and she has no plans to stop.

“My purpose in life is to advance health equity. I want to be able to say that I did all I could to ensure more people could both survive and thrive because they had easier access to health.”

View original content here.

https://www.3blmedia.com/sites/default/files/2024-06/Here-for-Good-%20A-steadfast-commitment-to-health-equity_Merck_061224.mp4

View additional multimedia and more ESG storytelling from Merck & Co., Inc. on 3blmedia.com.

Contact Info:
Spokesperson: Merck & Co., Inc.
Website: https://www.3blmedia.com/profiles/merck-co-inc
Email: info@3blmedia.com

SOURCE: Merck & Co., Inc.

View the original press release on accesswire.com

View the original press release on accesswire.com

Staff

Recent Posts

Coloplast announces changes to Executive Leadership Team

Today, Coloplast is announcing changes to the company’s Executive Leadership Team (ELT). The changes relate…

37 minutes ago

Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference

- The overview presentation will review some of the Company’s recent achievements as well as…

37 minutes ago

ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK

Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future…

37 minutes ago

TOMI Environmental Solutions Secures a Purchase Order of Approximately $500,000 for the Integration of SteraMist iHP Technology within a Global Biopharmaceutical Leader

FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ),…

37 minutes ago

Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

BOCA RATON, FLA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT)…

37 minutes ago

Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…

38 minutes ago